Detalles de la búsqueda
1.
Absolute risks of cervical precancer among women who fulfill exiting guidelines based on HPV and cytology cotesting.
Int J Cancer
; 146(3): 617-626, 2020 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30861114
2.
Association of HPV35 with cervical carcinogenesis among women of African ancestry: Evidence of viral-host interaction with implications for disease intervention.
Int J Cancer
; 147(10): 2677-2686, 2020 11 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32363580
3.
A Study of Partial Human Papillomavirus Genotyping in Support of the 2019 ASCCP Risk-Based Management Consensus Guidelines.
J Low Genit Tract Dis
; 24(2): 144-147, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-32243309
4.
Impact of human papillomavirus vaccination on the clinical meaning of cervical screening results.
Prev Med
; 118: 44-50, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30316878
5.
Effect of Several Negative Rounds of Human Papillomavirus and Cytology Co-testing on Safety Against Cervical Cancer: An Observational Cohort Study.
Ann Intern Med
; 168(1): 20-29, 2018 01 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29181509
6.
Adherence patterns to extended cervical screening intervals in women undergoing human papillomavirus (HPV) and cytology cotesting.
Prev Med
; 109: 44-50, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29288782
7.
Challenges in risk estimation using routinely collected clinical data: The example of estimating cervical cancer risks from electronic health-records.
Prev Med
; 111: 429-435, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29222045
8.
Low Risk of Cervical Cancer/Precancer Among Most Women Under Surveillance Postcolposcopy.
J Low Genit Tract Dis
; 22(2): 97-103, 2018 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-29570564
9.
Assessment of a New Lower-Cost Real-Time PCR Assay for Detection of High-Risk Human Papillomavirus: Useful for Cervical Screening in Limited-Resource Settings?
J Clin Microbiol
; 55(8): 2348-2355, 2017 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-28515214
10.
Why does cervical cancer occur in a state-of-the-art screening program?
Gynecol Oncol
; 146(3): 546-553, 2017 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28606721
11.
Risks of CIN 2+, CIN 3+, and Cancer by Cytology and Human Papillomavirus Status: The Foundation of Risk-Based Cervical Screening Guidelines.
J Low Genit Tract Dis
; 21(4): 261-267, 2017 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-28953116
12.
The population impact of human papillomavirus/cytology cervical cotesting at 3-year intervals: Reduced cervical cancer risk and decreased yield of precancer per screen.
Cancer
; 122(23): 3682-3686, 2016 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27657992
13.
Age-stratified 5-year risks of cervical precancer among women with enrollment and newly detected HPV infection.
Int J Cancer
; 136(7): 1665-71, 2015 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25136967
14.
A general binomial regression model to estimate standardized risk differences from binary response data.
Stat Med
; 32(5): 808-21, 2013 Feb 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-22865328
15.
Benchmarking CIN 3+ risk as the basis for incorporating HPV and Pap cotesting into cervical screening and management guidelines.
J Low Genit Tract Dis
; 17(5 Suppl 1): S28-35, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23519302
16.
Five-year risks of CIN 3+ and cervical cancer among women with HPV testing of ASC-US Pap results.
J Low Genit Tract Dis
; 17(5 Suppl 1): S36-42, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23519303
17.
Five-year risks of CIN 3+ and cervical cancer among women with HPV-positive and HPV-negative high-grade Pap results.
J Low Genit Tract Dis
; 17(5 Suppl 1): S50-5, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23519305
18.
Five-year risks of CIN 2+ and CIN 3+ among women with HPV-positive and HPV-negative LSIL Pap results.
J Low Genit Tract Dis
; 17(5 Suppl 1): S43-9, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23519304
19.
Five-year risks of CIN 3+ and cervical cancer among women who test Pap-negative but are HPV-positive.
J Low Genit Tract Dis
; 17(5 Suppl 1): S56-63, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23519306
20.
Five-year risk of CIN 3+ to guide the management of women aged 21 to 24 years.
J Low Genit Tract Dis
; 17(5 Suppl 1): S64-8, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23519307